Navigation Links
PDL BioPharma Provides Third Quarter 2009 Revenue Guidance of Approximately $71 Million
Date:9/8/2009

INCLINE VILLAGE, Nev., Sept. 8 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced revenue guidance for the third quarter ended September 30, 2009 of approximately $71 million, as compared with $69 million for the third quarter of 2008. Royalty revenues are based on second quarter product sales by PDL's licensees and include $1.6 million for Synagis(R), which is marketed by MedImmune. When compared with 2008, royalty revenue for foreign sourced sales was negatively impacted by changes in foreign exchange rates; approximately 50 percent of underlying product sales is in currencies other than U.S. dollars.

The above guidance is preliminary and actual published results may differ from such guidance. PDL plans to release its financial results for the third quarter 2009 on October 27, and will hold a conference call to discuss financial results and provide an update on company activities. Additional information regarding the call will be announced in late October.

About PDL BioPharma, Inc.

PDL BioPharma pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. PDL is focused on maximizing the value of its antibody humanization patents and related assets. The company receives royalties on sales of a number of humanized antibody products marketed today and also may receive royalty payments on additional humanized antibody products launched before patent expiry in late 2014. For more information, please visit www.pdl.com.

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.

Forward-looking Statements

This press release contains forward-looking
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Helix BioPharma Announces $13.5 Million Private Placement
2. Helix Biopharma to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
3. DOR BioPharma to Present at the Rodman & Renshaw Annual Global Investor Healthcare Conference
4. Eiger BioPharmaceuticals Appoints Paul Truex to Board of Directors
5. DOR BioPharma Reports 2nd Quarter and 1st Half 2009 Financial Results and Reviews Recent Accomplishments
6. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
7. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2009 Financial Results on Thursday, August 6, 2009 at 8:30am EDT
8. Eiger BioPharmaceuticals Acquires Exclusive License to Novel Hepatitis C Virus (HCV) Technology From Stanford University
9. DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD
10. PDL BioPharma to Present at BMO Capital Markets Healthcare Conference on August 5, 2009
11. Alexandria Real Estate Equities, Inc. Signs Biopharmaceutical Company, Lilly, as Anchor New York City Tenant at the Alexandria Center for Science and Technology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...25/PRNewswire/-Cytochromatodayannouncedtheappointm...illreplaceMr.UlrikSporkastheNovoA/Srepresentativeo...nchangedatsixmembers. ,, "Weareverypleasedtowel...fromhisexperienceandguidanceasCytochromacontinuest...ypharmaceuticalcompany,"statedAlanLewis,PhD,Chairm...
(Date:11/24/2009)...PRNewswire-FirstCall/--IES(Nasdaq: IESC ),aleading...msandservicesforthecommercial,industrialandresiden...sgrouphasbeenawardedacontractfromManhattanTorconJV...ylab(BSL-4)replacementfacilityattheU.S.ArmyMedical...ortDetrickinFrederick,Md. ,, ThenewUSAMRIIDrepl...
(Date:11/24/2009)...nd,November24/PRNewswire-FirstCall/--deCODE,geneti...vednoticefrom,theNasdaqStockMarketthattradinginthe...,2009andaForm25-NSEwillbefiledwiththe,Securitiesan...tock,fromlistingonNasdaq,unlessthecompanyfilesanap...anyhasfiledsuchanappeal,which,willstaythesuspensio...
(Date:11/24/2009)...,Nov.24/PRNewswire-FirstCall/--NeurogesX,Inc.(Nasd...opingandcommercializingnovelpainmanagementtherapie...efExecutiveOfficer,isscheduledtopresentatthe21stAn...ber1-2,2009atTheNewYorkPalaceHotelinNewYork,NewYor...ialOfficer,willbeavailabletorespondtoquestionsduri...
Breaking Biology Technology:Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3
..., , , , , , , Multipo... , , , , , .... 4308 915.526 01/2002 , , , ..., , Microorganism , ... Cell type , Bacteria, gram positi...
..., , , , , , , Multipo... , , , , , .... 4308 915.522 03/2002 , , , ..., , Microorganism , ... , Cell type , Bacteria, ...
..., , , , , , , Multipo... , , , , , .... 4308 915.519 12/2001 , , , ..., , Microorganism , ..., Cell type , Bacteria, gram...
Other Biology Technology:Nocardia corallina 2Mycobacterium smegmatis 2Lactococcus lactis 2
(Date:11/24/2009)...RI) today named 12 new grant recipients for 2009. ...ative work across a broad spectrum of lupus resear...y, and potential to drive scientific discovery to ...sease of systemic lupus. , The 2009 grants go to... the nation and include interdisciplinary and high...
(Date:11/24/2009)...protein that may help gut bacteria bind to the gas...probiotic producers to identify strains that are l...ics need to interact with cells lining the gut to ...rfaces in the gut they are more likely to stick ar... Nathalie Juge from the Institute of Food Research...
(Date:11/24/2009)...markable class of ring-shaped protein motors has b...keley National Laboratory (Berkeley Lab) using a s...t the Advanced Light Source (ALS). These protein m...plication, and are vital to the survival of all bi... as the human papillomavirus, which has been linke...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3A sticky solution for identifying effective probiotics 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Bones May Suffer From Green Tea Consumption 57484 1Swine Flu Loves a Crowd 57482 1Swine Flu Loves a Crowd 57482 2Swine Flu Loves a Crowd 57482 3Swine Flu Loves a Crowd 57482 4Dr Michael Guthrie Named to PerfectServe Advisory Board 57481 1Dr Michael Guthrie Named to PerfectServe Advisory Board 57481 2
... Institute for Energy Efficiency has awarded its f... Stanford faculty. John P. Weyant, deputy director...s will receive a total of $358,000 over the next 1...ergy efficiency in the transportation, building an...sued our first campus-wide call for innovative pro...
...ed to roast coffee beans could give Britain,s biom...f some of the UKs leading energy crops by up to 20...from the University of Leeds, examined the combust...gy creation when put through a mild thermal proces...h coffee production. , Torrefaction is increasing...
...release is available in German . , , Bonn/Berlin...e long term" How much do national economies need t...price will we have to pay if we do not act" These ...systems and Biodiversity - project is seeking to a...s head of Deutsche Bank,s Global Market Centre in ...
Other Biology News:Precourt Institute for Energy Efficiency awards first faculty research grants 2Biodiversity as a natural resource 2
...-up, these culture chambers produce cell yields in...s to multiple roller bottles or spinner flasks. &b...l integrity • 100% leak tested prior to shipp...y gamma irradiation, with low particulate contamin...
Taq DNA Polymerase (with KCl buffer) from ABgene
Buffer for sal I 10X (do not list in catalog) BLACK (Sal I) from Sigma-Aldrich
... thermostable DNA polymerase obtained by high leve...coli, Concentration: 5U/ul, Applications: Standard...world leader in serving science. Thermo Fisher Sci...ier, cleaner and safer by providing analytical ins...
Biology Products: